Friday, August 6th, 2010 at
4:29 pm
Helix BioMedix Reports Second Quarter 2010 Financial Results
BOTHELL, Wash.–(BUSINESS WIRE)–Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, today announced financial results for the company’s second quarter 2010 ended June 30, 2010. Second Quarter 2010 and Recent Highlights: Recorded record revenue of approximately $330,000 in the second quarter of 2010, compared to approximately $138,000 in the same period a year ago, an increase …
Read more on Business Wire
Friday, July 30th, 2010 at
6:58 am
Reliv International Reports Second-Quarter 2010 Results
News), a nutrition and direct selling company, today reported consolidated net sales of $18.8 million for the second quarter of 2010, compared to net sales of $20.1 million in the second quarter of last year. Â International sales rose 18.7 percent compared to the same quarter in 2009, but U.S. sales were down 9.5 percent in the quarter.
Read more on PR Newswire via Yahoo! Finance
Tuesday, June 29th, 2010 at
5:45 pm
Ekson Farma, Istanbul, Turkey, Reports Activar(R) AC-11(R) Next Generation Anti-Aging Skin Care and Oral Supplement …
NEW YORK, NY–(Marketwire – 06/28/10) – Optigenex Inc. (Pinksheets: OPGX – News ) announced today its partner in Turkey, Ekson Farma, reports sales of its family of skin care products and oral supplements under the brand name, Activar with AC-11, is gaining support among a variety of health conscious and educated consumers in Turkey. Ekson, an exclusive licensee since early 2008, devoted nearly …
Read more on Marketwire via Yahoo! Finance
